Vivactis HM3A is a consultancy agency specialized in market access and health economics for pharmaceuticals, biotechnological products, medical devices and digital health, diagnostics, vaccines, and nutrinomics.
The Vivactis group offers an international coverage. Our Market Access Services can support your EU and international market launches. We have access to highly qualified local experts in these markets.
Our consultants have many years of experience in determining and executing Pricing and Reimbursement strategy and tactics.
For each project we can assign a custom project team with relevant expertise. The team members can build upon the expertise and experience of the group as sharing knowledge is within our DNA. Our team includes physicians, pharmacists, science PhDs and health economists with a track record at pharmaceutical/medical device companies, within healthcare authorities, and as practicing healthcare providers.
Description of activities
Strategic market access advice
We simplify and accelerate your market access by advising you about legal and regulatory requirements and regional specifics.
We create strategic plans that can:
- help you identify areas of evidence generation you will need
- support you to better position your product for acquisition or licensing
We study the payer coverage, segmentation and engagement. We help identify who the payers are, what their point of view is and how to communicate the value of your product or service to them.
KOL management, advisory boards and Delphi panels
We ensure optimal relationship with experts to understand the market, add knowledge and scientific data, cost data and validation. We ensure the logistics of panels and the reporting of the panels.
Pricing and reimbursement, managed entry agreements
We advise on the price and reimbursement strategy for your product or service. Our team develops, submits and follows-up price and reimbursement dossiers. We prepare, submit and follow-up MEAs including data collection, processing and reporting.
Health economic modelling and analysis
We provide strategic advice and help to choose and implement the right methodology. We develop models or validate and adapt existing models for one or many countries. We collect data in by analysing databases, reviewing literature, analysing expert opinions, …
Global Value Dossiers (GVD) and Health Technology Assessment (HTA) intelligence and support
We write GVDs with a focus on both therapeutic and economic value, we work with you on HTA submissions
Barbara D’haene, PhD, COO